关注
Wei-Min Chung, WM Chung
Wei-Min Chung, WM Chung
Department of biochemistry, China Medical University, Taiwan
在 mail.cmu.edu.tw 的电子邮件经过验证
标题
引用次数
引用次数
年份
MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro
WM Chung, WC Chang, L Chen, YY Chang, CR Shyr, YC Hung, WL Ma
Stem cell research & therapy 4, 1-10, 2013
392013
Increase paclitaxel sensitivity to better suppress serous epithelial ovarian cancer via ablating androgen receptor/aryl hydrocarbon receptor-ABCG2 axis
WM Chung, YP Ho, WC Chang, YC Dai, L Chen, YC Hung, WL Ma
Cancers 11 (4), 463, 2019
272019
Androgen/androgen receptor signaling in ovarian cancer: molecular regulation and therapeutic potentials
WM Chung, L Chen, WC Chang, SY Su, YC Hung, WL Ma
International journal of molecular sciences 22 (14), 7748, 2021
262021
Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line
L Chen, WC Chang, YC Hung, YY Chang, BY Bao, HC Huang, ...
Reproductive sciences 21 (3), 386-394, 2014
252014
LDLR-mediated lipidome–transcriptome reprogramming in cisplatin insensitivity
WC Chang, HC Wang, WC Cheng, JC Yang, WM Chung, YP Ho, L Chen, ...
Endocrine-related cancer 27 (2), 81-95, 2020
202020
Ligand-independent androgen receptors promote ovarian teratocarcinoma cell growth by stimulating self-renewal of cancer stem/progenitor cells
WM Chung, WC Chang, L Chen, TY Lin, LC Chen, YC Hung, WL Ma
Stem cell research 13 (1), 24-35, 2014
202014
Non‐Genomic Estrogen/Estrogen Receptor α Promotes Cellular Malignancy of Immature Ovarian Teratoma In Vitro
YC Hung, WC Chang, LM Chen, YY Chang, LY Wu, WM Chung, TY Lin, ...
Journal of Cellular Physiology 229 (6), 752-761, 2014
192014
Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer
JC Yang, N Chang, DC Wu, WC Cheng, WM Chung, WC Chang, FJ Lei, ...
Journal of Cellular and Molecular Medicine 23 (11), 7417-7426, 2019
112019
Androgen receptor enhances the efficacy of sorafenib against hepatocellular carcinoma through enriched EpCAM stemness
HC Lai, WM Chung, CM Chang, PY Liao, YT Su, CC Yeh, LB Jeng, ...
Anticancer research 40 (3), 1285-1295, 2020
52020
Low-density lipoprotein receptor-mediated lipidome-transcriptome reprogramming impulses to cisplatin insensitivity
WC Chang, HC Wang, WC Cheng, JC Yang, WM Chung, L Chen, YP Ho, ...
bioRxiv, 502401, 2018
12018
Androgen receptor sensitized sorafenib efficacy via enriched EPCAM stemness in hepatocellular carcinoma
HC Lai, WL Ma, WM Chung, CM Chang, CC Yeh, LB Jeng
Journal of Hepatology 73, S650, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–11